|
April. 10, 2026 |
|
|
July. 16, 2026 |
|
|
jRCT2031260035 |
A phase IIb, Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group, Dose-Ranging Study of M610101 in Patients with Nonsegmental Vitiligo |
|
A phase IIb, Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group, Dose-Ranging Study of M610101 in Patients with Nonsegmental Vitiligo |
Nishiura Tomoyuki |
||
Maruho Co.,Ltd. Kyoto R&D Center |
||
93 Chudoji Awatacho, Shimogyo-ku, Kyoto |
||
+81-75-325-3279 |
||
ctinfo@mii.maruho.co.jp |
||
- Clinical Trials Information |
||
Maruho Co.,Ltd. Kyoto R&D Center |
||
93 Chudoji Awatacho, Shimogyo-ku, Kyoto |
||
+81-75-325-3279 |
||
ctinfo@mii.maruho.co.jp |
Recruiting |
April. 10, 2026 |
||
| May. 13, 2026 | ||
| 120 | ||
Interventional |
||
randomized controlled trial |
||
double blind |
||
placebo control |
||
parallel assignment |
||
treatment purpose |
||
(1) Participants aged 12 years and older with a clinical diagnosis of non-segmental vitiligo |
||
(1) Patients complicated with diseases considered inappropriate for participation in clinical trials such as serious cardiac / hepatic / renal / pulmonary / hematologic disease |
||
| 12age old over | ||
| No limit | ||
Both |
||
Non-segmental vitiligo |
||
Apply 2 times a day. |
||
Proportion of participants achieving F-VASI75 at Week 24. |
||
| Maruho Co.,Ltd. |
| Medical corporation Shintoukai Yokohamaminoru Clinic IRB | |
| 1-13-8, Bessho Minami-ku Yokohama-shi, Kanagawa | |
+81-42-648-5551 |
|
| yminoru-irb@eps.co.jp | |
| Not approval | |
April. 16, 2026 |
No |
none |